Pegaptanib: vascular endothelial growth factor inhibition in age-related macular degeneration

ISSN： 1745-509X

Source： Aging Health, Vol.3, Iss.3, 2007-06, pp. : 287-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ranibizumab in the treatment of age-related macular degeneration

By Singh Rishi P Schachat Andrew

Aging Health, Vol. 3, Iss. 1, 2007-02 ,pp. : 9-14

Future Medicine

Access to resources Recommend Favorite

Carotenoid compounds reduce risk of age-related macular degeneration

Aging Health, Vol. 3, Iss. 5, 2007-10 ,pp. : 581-583

Future Medicine

Access to resources Recommend Favorite

Optic disc image in advanced age-related macular degeneration

By Law Simon K

Aging Health, Vol. 5, Iss. 6, 2009-12 ,pp. : 733-741

Future Medicine

Access to resources Recommend Favorite

Do eyes after cataract surgery have an increased risk of age-related macular degeneration?

By Wang Jie Jin

Aging Health, Vol. 4, Iss. 6, 2008-12 ,pp. : 597-602

Future Medicine

Access to resources Recommend Favorite

Insulin-like growth factor-1 is a mediator of age-related decline of bone health status in men

By Chin Kok-Yong Ima-Nirwana Soelaiman Mohamed Isa Naina Hanapi Johari Mohamad Ahmad Fairus Mohamed Ramli Elvy Suhana Wan Ngah Wan Zurinah

The Aging Male, Vol. 17, Iss. 2, 2014-06 ,pp. : 102-106

Informa Healthcare

Access to resources Recommend Favorite